The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, International Stem Cell's share price is $0.109.
International Stem Cell's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.98. Hence, International Stem Cell's PS Ratio for today is 0.11.
The historical rank and industry rank for International Stem Cell's PS Ratio or its related term are showing as below:
ISCO'
s PS Ratio Range Over the Past 10 Years
Min: 0.05 Med: 0.71 Max: 5.25
Current: 0.11
During the past 13 years, International Stem Cell's highest PS Ratio was 5.25. The lowest was 0.05. And the median was 0.71.
ISCO's PS Ratio is ranked better than 99.6% of 1000
companies
in the Biotechnology industry
Industry Median: 9.14
vs ISCO: 0.11
International Stem Cell Corp revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of International Stem Cell was -5.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 1.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -9.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -19.00% per year.
During the past 13 years, International Stem Cell's highest 3-Year average Revenue per Share Growth Rate was 475.80% per year. The lowest was -33.10% per year. And the median was -14.70% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of International Stem Cell's PS Ratio
For the Biotechnology subindustry, International Stem Cell's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Stem Cell's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, International Stem Cell's PS Ratio distribution charts can be found below:
* The bar in red indicates where International Stem Cell's PS Ratio falls into.
International Stem Cell PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
International Stem Cell's Share Price of today is $0.109. International Stem Cell's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.98.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
International Stem Cell (OTCPK:ISCO) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
International Stem Cell PS Ratio Related Terms
Thank you for viewing the detailed overview of International Stem Cell's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
International Stem Cell (International Stem Cell) Business Description
International Stem Cell Corp is a clinical-stage biotechnology company. It is focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities. The company develops different cell types from its stem cells that may result in therapeutic products. The clinical applications of the company include neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; Liver cells, which are used to treat a variety of congenital and acquired liver diseases; and retinal cells and three-dimensional eye structures. It operates in three segments, the therapeutic market, the biomedical market, and the anti-aging market. The Biomedical products business segment accounts for the majority of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ISCO has been successfully added to your 